ClinicalTrials.gg
Sign In

Drug

Alpha-tocotrienol quinone clinical trials

Also written EPI-743, Vatiquinone and PTC743.

studies test it
18
open now
1
in phase 3
5
first study started
2012

Keep track of what changes. Save the alpha-tocotrienol quinone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

EPI-743
12
PTC743
4

Other names

Vatiquinone
6

Studies by the year they started

18 studies that test it; most in 2012 (4)

Studies that test alpha-tocotrienol quinone, by start year
YearStudies
20124
20134
20144
20202
20223
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
14
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it.

Friedreich Ataxia
4
Syndrome
2
Ataxia
2
Mitochondrial Diseases
1
Hearing Loss, Noise-Induced
1
Rett Syndrome
1
Homocystinuria
1
Parkinson Disease
1
Tourette Syndrome
1
MELAS Syndrome
1
Autistic Disorder
1

Who runs them

Industry 13 · Other 5

PTC Therapeutics (9) · Edison Pharmaceuticals Inc (4) · University of South Florida (2) · National Human Genome Research Institute (NHGRI) (1) · Bambino Gesù Hospital and Research Institute (1) · Yale University (1)

Studies

Open first, then newest update. How each study uses alpha-tocotrienol quinone is read from its arms, and is right about nine times in ten.

Testing it · 18

Codes

What other systems call alpha-tocotrienol quinone · ClinicalTrials.gg INT006038

  • MeSH (NLM) C571746alpha-tocotrienol quinoneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 6O85FK9I0XVATIQUINONEConfirmed FDA, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.